Paxlovid Boceprevir Intermediate CAS 565456-77-1 Assay ≥99.0%
Ubonelelo ngezoRhwebo PF-07321332 Paxlovid abaPhakathi abaNxungupheleyo abanoMgangatho oPhezulu
I-L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
I-Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
I-Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Igama leMchiza | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Izithethantonye | I-Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Inombolo yeCAS | 565456-77-1 |
Inombolo yeCAT | RF-PI318 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C9H15NO2.ClH |
Ubunzima beMolekyuli | 205.683 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Isazisi A | I-IR: Ifana neNgcaciso yeNgcaciso |
Isazisi B | Ixesha lokuGcina: Liyafana neNxibelelwano yeSiza |
I-Enantiomer | ≤0.15% |
Ukungcola okunxulumeneyo (nge-HPLC) | |
Ukungacoceki okungaziwayo | ≤0.20% |
Ukungcola ngokupheleleyo | ≤1.0% |
Amanzi | ≤0.50% |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤20ppm |
Isivavanyi | ≥99.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Phakathi kwe-PF-07321332 Paxlovid (CAS 2628280-40-8) kunye ne-Boceprevir (CAS 394730-60-0) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) i-azabicyclohexane derivative esetyenziselwa ukulungiswa kwe-hepatitis C. intsholongwane (HCV) NS3 serine protease inhibitor.Kuphakathi kwe-PF-07321332 Paxlovid (CAS 2628280-40-8) kunye ne-Boceprevir (CAS 394730-60-0).PF-07321332 inamandla kwaye iyasebenza ngomlomo i-SARS-CoV 3C-efana ne-protease (3CLPRO) inhibitor.PF-07321332 ekujoliswe kuyo kwintsholongwane ye-SARS-CoV-2 kwaye inokusetyenziselwa uphando lwe-COVID-19.I-Boceprevir (INN, igama lokurhweba i-Victrelis) yi-protease inhibitor esetyenziswa njengonyango lwe-hepatitis C genotype 1. Ibophelela kwi-HCV nonstructural 3 NS3 (HCV) indawo esebenzayo.Yayiphuhliswa yi-Schering-Plough, kodwa ngoku iphuhliswa yi-Merck ukususela ekubeni i-Schering yafunyanwa ngo-2009. Yavunywa yi-FDA ngoMeyi 13, 2011.